Abstract

Persister cells (PCs) are a subset of dormant, phenotypic variants of regular bacteria, highly tolerant to antibiotics. Generation of PCs in vivo may account for the recalcitrance of most chronic infections to antimicrobial treatment and demands for the identification of new antimicrobial agents able to target such cells. The present study explored the possibility to obtain in vitro PCs of Pseudomonas aeruginosa and Staphylococcus aureus at high efficiency through chemical treatment, and to test their susceptibility to structurally different antimicrobial peptides (AMPs) and two clinically used peptide-based antibiotics, colistin and daptomycin. The main mechanism of action of these molecules (i.e., membrane-perturbing activity) renders them potential candidates to act against dormant cells. Exposure of stationary-phase cultures to optimized concentrations of the uncoupling agent cyanide m-chlorophenylhydrazone (CCCP) was able to generate at high efficiency PCs exhibiting an antibiotic-tolerant phenotype toward different classes of antibiotics. The metabolic profile of CCCP-treated bacteria was investigated by monitoring bacterial heat production through isothermal microcalorimetry and by evaluating oxidoreductase activity by flow cytometry. CCCP-pretreated bacteria of both bacterial species underwent a substantial decrease in heat production and oxidoreductase activity, as compared to the untreated controls. After CCCP removal, induced persisters showed a delay in heat production that correlated with a lag phase before resumption of normal growth. The metabolic reactivation of bacteria coincided with their reversion to an antibiotic-sensitive phenotype. Interestingly, PCs generated by CCCP treatment resulted highly sensitive to three different membrane-targeting AMPs at levels comparable to those of CCCP-untreated bacteria. Colistin was also highly active against PCs of P. aeruginosa, while daptomycin killed PCs of S. aureus only at concentrations 32 to 64-fold higher than those of the tested AMPs. In conclusion, CCCP treatment was demonstrated to be a suitable method to generate in vitro PCs of medically important bacterial species at high efficiency. Importantly, unlike conventional antibiotics, structurally different AMPs were able to eradicate PCs suggesting that such molecules might represent valid templates for the development of new antimicrobials active against persisters.

Highlights

  • Within an isogenic bacterial population, persister cell (PC) comprise a small subpopulation of non-growing, metabolically quiescent cells that exhibit high tolerance to antibiotics (Keren et al, 2004; Lewis, 2010)

  • We first assessed the susceptibility of stationary-phase cultures of P. aeruginosa and S. aureus to carbonyl cyanide m-chlorophenylhydrazone (CCCP) in order to identify the concentrations able to ensure maximum cell survival

  • The optimal concentration of CCCP and exposure time required for the induction of persistence in stationary-phase cultures of P. aeruginosa and S. aureus were established based on the acquisition of tolerance to antibiotics following the treatment with CCCP

Read more

Summary

Introduction

Within an isogenic bacterial population, PCs comprise a small subpopulation of non-growing, metabolically quiescent cells that exhibit high tolerance to antibiotics (Keren et al, 2004; Lewis, 2010). Unlike drug-resistant bacteria, PCs survive antibiotic treatments by reducing their metabolism and entering into a dormant state without undergoing genetic changes. They do not proliferate in the presence of antibiotics, but they resume growth after the removal of the drug, giving rise to a population genetically identical to the original one and susceptible to antibiotics (Balaban et al, 2004; Kwan et al, 2013). As the elimination of PCs seems crucial to improve the management of chronic biofilm-associated infections, the development of novel antimicrobial agents able to target such cells is emerging as a research priority (Conlon et al, 2013; Zhang, 2014)

Methods
Results
Discussion
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.